July 2018

Creating a sustainable manufacturing sector, capable of meeting international standards, and building export competences is a key component of President Ramaphosa’s strategy to attract investment to South Africa. And it looks like it is working following the announcement from Mercedes-Benz that it would invest R10 billion into its Eastern Cape manufacturing plant.

But there is another perhaps less well-known company looking to boost its manufacturing ability in order to grow an export market. Our lead feature for July comes from healthcare manufacturing business Biovac. The Cape Town-based company develops and manufactures vital vaccines that immunise against deadly diseases. A recent partnership between Biovac, and American company PATH will see Biovac manufacture a GBS vaccine for export around Africa.

CEO, Dr Morena Makhoana is excited about the potential for the company and tells Enterprise Africa that his hope is to become a multi-geographic, multi-disciplinary, South African healthcare manufacturing business that works for local and international markets.

We also hear from Standard Lesotho Bank about the company’s move towards a digital future. CIO, Sam Koatla tells us that he sees big opportunities for growth in a country which still lags behind international uptake standards when it comes to digital banking.

And then there’s Graysmaker Advisory, an investment business with a unique offering for local and international investors, that is helping to drive Southern Africa’s renewable energy scene.

All of these businesses are helping to bring FDI into Africa, and boosting the industries and communities in which they operate.

Get in touch and tell us about how your business is drawing the eyes of the world to the continent, we’re online @EnterpriseAfri1